Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2009 | 03-2009 | 12-2008 | 09-2008 | 06-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,380 | -2,380 | -10,270 | -7,460 | -5,050 |
| Depreciation Amortization | 340 | 170 | 660 | 510 | 340 |
| Accounts payable and accrued liabilities | N/A | N/A | -188 | N/A | N/A |
| Other Working Capital | 420 | 10 | -360 | -170 | -460 |
| Other Operating Activity | 1,580 | 540 | 3,038 | 1,890 | 1,380 |
| Operating Cash Flow | $-4,040 | $-1,660 | $-7,120 | $-5,230 | $-3,790 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | -3,986 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 8,000 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -4 | 2,920 | 2,110 |
| Investing Cash Flow | $0 | $0 | $4,010 | $2,920 | $2,110 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,060 | 360 | 2,640 | 2,400 | 1,320 |
| Financing Cash Flow | $5,060 | $360 | $2,640 | $2,400 | $1,320 |
| Beginning Cash Position | 2,790 | 2,790 | 3,260 | 350 | 350 |
| End Cash Position | 3,810 | 1,490 | 2,790 | 440 | 5 |
| Net Cash Flow | $1,010 | $-1,290 | $-460 | $90 | $-340 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,040 | -1,660 | -7,120 | -5,230 | -3,790 |
| Free Cash Flow | -4,040 | -1,660 | -7,120 | -5,230 | -3,790 |